Join us for free webinar on ORCID adoption by research funding organizations
ORCID is partnering with the Health Research Alliance, a consortium of biomedical research foundations, to host a free webinar on how funders are using ORCID identifiers in their workflows and systems. Join us to learn why funders at public and private funding organizations in the U.S. and Europe are integrating ORCID identifiers into common CV platforms, mandating use during grant submission, and leveraging identifiers to improve tracking and evaluation.
.JPG){kind=logo}
Funding organizations including the U.S. National Institutes of Health, U.S. Department of Energy and the Wellcome Trust have integrated ORCID iDs into their systems. Some funders have started to require ORCID identifiers during grant submission, including Autism Speaks and Fundação para a Ciência e a Tecnologia (FCT, Portugal). To enable researchers to link to their existing funding information, earlier this year ORCID worked with ÜberResearch to launch a free search and link funding tool, available through the ORCID interface.
Event details:
- 25 September 2014, 10 am EDT (UTC-4)
- Free to participate!
- Please register in advance
- Learn more about the event program
ORCID provides a registry of unique, persistent identifiers for researchers that is open, non-proprietary, transparent, mobile, and community-based. ORCID provides each researcher with a unique identifier and can unambiguously link scholars with their research outputs. Adoption of ORCID identifiers by research funders enables research funders to more accurately link their grantees and their outcomes with the funding provided. By integrating ORCID identifiers across the research workflow, from original grant application through grant tracking and reporting and on to publication and citation of results, the research and scholarly community will be better able to distinguish the unique contributions of individuals as authors, researchers, grantees, faculty, trainees, students, and inventors.
We hope you can join us. Questions? Please contact us at [email protected].
